Associated Papers
Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trials.
González-Gil C et al.
Hemasphere, 2025
40420999 (PubMed )
Supplement: HEM3-9-e70148-s007.xlsx › SNV
Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy.
Zerella JR et al.
Frontiers in Oncology, 2023
Gain-of-function IKZF1 variants in humans cause immune dysregulation associated with abnormal T/B cell late differentiation.
Hoshino A et al.
Science Immunology, 2022
AIOLOS Variants Causing Immunodeficiency in Human and Mice.
Yamashita M et al.
Frontiers in Immunology, 2022
A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS.
Yamashita M et al.
Nature Immunology, 2021
A Point Mutation in IKAROS ZF1 Causes a B Cell Deficiency in Mice.
Boast B et al.
Journal of Immunology (baltimore, Md. : 1950), 2021
Ikaros-Associated Diseases: From Mice to Humans and Back Again.
Boast B et al.
Frontiers in Pediatrics, 2021
Familial Immune Thrombocytopenia Associated With a Novel Variant in IKZF1.
Sriaroon P et al.
Frontiers in Pediatrics, 2019
Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency.
Boutboul D et al.
The Journal of Clinical Investigation, 2018
The Ikaros family in lymphocyte development.
Heizmann B et al.
Current Opinion in Immunology, 2018
Loss of B Cells in Patients with Heterozygous Mutations in IKAROS.
Kuehn HS et al.
The New England Journal of Medicine, 2016
B-lineage transcription factors and cooperating gene lesions required for leukemia development.
Tijchon E et al.
Leukemia, 2013
Select a paper to view details